Vivo Infusion
Vivo Infusion is a PE-backed operator of nearly 80 outpatient ambulatory infusion centers across 15 U.S. states, delivering in-network IV therapy for autoimmune, neurological, oncological, and rare-disease patients via physician referrals, integrated specialty pharmacies, and JCAHO-certified clinical research infrastructure.
- Company typePrivate
- Founded2022
- HeadquartersLakewood, United States
- Headcount501–1,000
- GTM typeB2B and B2C
- OfferingServices
What Vivo Infusion does
Vivo Infusion is a private, PE-backed operator of outpatient ambulatory infusion centers providing IV therapy administration for chronic and acute conditions including autoimmune disorders (Multiple Sclerosis, Rheumatoid Arthritis, Lupus, Crohn's), neurological conditions, immune deficiencies, oncology, and rare genetic disorders. The company is the product of a multi-year roll-up: founded via the 2022 acquisitions of Healthcare Evolution Specialty Pharmacy (HCEV) and Infusion Center of Pennsylvania (ICPA), then scaled through acquisitions of CIVIC Infusion (January 2023), Specialty Infusion Centers (June 2023), Infusion Associates (July 2024), and Neurology Institute of San Antonio / Vista Infusions (January 2025). It is headquartered in Lakewood, Colorado and operates nearly 80 centers across 15 states.
The platform layers three integrated capabilities on top of the infusion center footprint. First, an embedded specialty pharmacy network (2nd Avenue Pharmacy, Medicine Chest Plus, HCEV) that dispenses directly into the centers, reducing dependency on third-party specialty pharmacy arrangements. Second, a JCAHO-certified Clinical Research Network that provides monitored storage, on-site pharmacy preparation, and trained research nurses, enabling the company to participate in sponsor clinical trials as a site. Third, a Patient Care Navigator function that handles scheduling, insurance verification, prior authorizations, and financial assistance — operational infrastructure that translates the clinical referral into a delivered infusion visit.
Commercially, Vivo runs a B2B2C model in which referring physicians (rheumatologists, neurologists, oncologists, gastroenterologists, and other specialists) drive patient flow, while revenue is collected from commercial insurance, Medicare, Medicare Advantage, and Medicaid as an in-network provider. The company is deliberately priced below hospital outpatient infusion via a no-facility-fee policy, positioning the platform as a cost-effective alternative to hospital-administered infusion. InTandem Capital Partners is the controlling private equity sponsor and raised nearly $150 million in additional equity in 2024 to fund continued M&A and expansion.
Vivo Infusion firmographics
Firmographics- Name
- Vivo Infusion
- Legal name
- Vivo Infusion
- Website
- https://vivoinfusion.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Vivo Infusion is a PE-backed operator of nearly 80 outpatient ambulatory infusion centers across 15 U.S. states, delivering in-network IV therapy for autoimmune, neurological, oncological, and rare-disease patients via physician referrals, integrated specialty pharmacies, and JCAHO-certified clinical research infrastructure.
- Ownership category
- akta.pro rank
Vivo Infusion industry classification
Industry- Product category
- Ambulatory Infusion Services
- NAICS
- All Other Outpatient Care Centers (621498), Outpatient Care Centers (6214)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Infusion Therapy Centers (Outpatient) (HLAFABAF)
- akta.pro secondary industries
- Infusion & Home Infusion Pharmacy Services (HLAFALAG), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
Keywords
Where Vivo Infusion is headquartered
LocationHeadquarters
- HQ city
- Lakewood
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vivo Infusion business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Infusion Therapy Services: Vivo Infusion generates revenue by providing outpatient infusion therapy services at its ambulatory infusion centers. Services are billed to insurance payers including commercial insurance, Medicare, Medicare Advantage, and Medicaid. The company is in-network with all major payers and does not charge facility fees unlike hospital-based settings.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance-based service model with in-network provider status |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Vivo Infusion product offering
Product offeringCore offering
Vivo Infusion operates a national network of outpatient ambulatory infusion centers providing personalized IV therapy for chronic and complex conditions. The company administers over 100 advanced infusion therapies including monoclonal antibodies, immune globulin therapies, enzyme replacement therapies, TNF alpha inhibitors, and chemotherapy, integrated with in-house specialty pharmacies and a clinical research program that supports investigational infusion products at JCAHO-certified facilities.
Product overview
Vivo Infusion is an ambulatory infusion center network offering a unified platform of infusion therapy services. The core offering consists of outpatient infusion center operations spanning approximately 80+ centers across 15 states, supplemented by integrated specialty pharmacy services and a clinical research network. The portfolio includes acquired brands (CIVIC Infusion, Infusion Associates, Vista Infusions, Specialty Infusion) operating under the unified Vivo Infusion brand, delivering over 100 treatment types for autoimmune, neurological, oncological, and rare genetic conditions.
Differentiator
Problem solved
Functional benefit
Products and services
- Ambulatory Infusion Center Services Outpatient ambulatory infusion center network of approximately 80 sites across 15 U.S. states providing personalized IV therapy for chronic and acute conditions, with flexible weekday and weekend scheduling, private suites, reclining chairs, free parking, and complimentary Wi-Fi and snacks. Patients are referred by specialists and supported by Patient Care Navigators.
- Infusion Therapy Treatments Over 100 advanced infusion therapies including monoclonal antibodies, immune globulin therapies, enzyme replacement therapies, TNF alpha inhibitors, and chemotherapy, treating autoimmune diseases, neurological disorders, cancer, immune deficiencies, and rare genetic conditions.
- Specialty Pharmacies Integrated in-house specialty pharmacies (2nd Avenue Pharmacy, Medicine Chest Plus Pharmacy, Healthcare Evolution) serving patients with cancer, multiple sclerosis, rheumatoid arthritis, and rare genetic conditions. Pharmacists coordinate with ambulatory care sites to deliver optimal therapies at competitive pricing.
- Clinical Research Network Clinical research program enabling administration of infusion-based investigational products through collaboration with research leaders. Includes experienced infusion nurses, monitored storage, and private or semi-private treatment areas within JCAHO-certified facilities.
- Provider Referral Services Referral processing for physicians including benefit verification, prior authorization support, scheduling coordination, and ongoing communication. Patient Care Navigators guide patients through scheduling and financial assistance programs.
- Financial Planning Services Financial planning support including insurance verification, copay assistance program navigation, and flexible financing options. Does not charge facility fees like hospital-based facilities.
Companies that use Vivo Infusion
Customer profileSegments1 record
Ideal customer profiles2 records
Vivo Infusion technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Vivo Infusion partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- Neurology Institute of San AntoniominorVivo Infusion announced the acquisition of the Neurology Institute of San Antonio along with Vista Infusions, expanding its presence in Texas and adding neurological infusion services to its capabilities.
- Vista InfusionsminorAcquired alongside Neurology Institute of San Antonio, Vista Infusions represents an expansion of Vivo Infusion's Texas footprint.
- Infusion AssociatescoreAcquired in July 2024, Infusion Associates operates ambulatory infusion centers in Michigan, Minnesota, Ohio, and Wisconsin. This acquisition significantly expanded Vivo Infusion's Midwest presence to nearly 80 total centers across 15 states.
- CIVIC InfusioncoreCIVIC Infusion was acquired in January 2023, expanding Vivo Infusion's network to 36 infusion centers across 9 states. The acquisition included integration of CIVIC's founders, MDs Barry D. Stein and Robert M. Roteman, as Medical Directors.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Vivo Infusion competitors and assessment
Company assessmentDirect peers
- IVX Health: Operates a national network of outpatient infusion centers delivering IV therapies for chronic conditions, with a patient experience and physician-referral GTM nearly identical to Vivo Infusion's model.
- Soleo Health: Specialty infusion services provider offering home and alternate-site infusion for complex conditions including immunology, neurology, and infectious disease; private equity-backed with comparable therapeutic mix to Vivo.
- Pentec Health: Specialty infusion and nutrition provider serving patients with chronic conditions in home and clinical settings; overlap with Vivo in enteral/parenteral therapies and disease-state infusion management.
- KabaFusion: National provider of home and specialty infusion therapies with focus on immunoglobulin and chronic disease infusions; comparable patient mix and chronic-condition model to Vivo's clinical offerings.
Broad incumbents
- Option Care Health: Largest U.S. provider of home and alternate-site infusion services, including ambulatory infusion. Operates at significantly greater scale than Vivo and is publicly traded, providing a direct public-market comparable.
- Coram (CVS Health): CVS Health's national home infusion and specialty infusion arm; competes for the same chronic-disease infusion volume, particularly with payers that contract across CVS's vertically integrated platform.
- BioPlus Specialty Pharmacy (Elevance Health): Specialty pharmacy within Elevance Health that integrates dispensing with infusion services; competes with Vivo's specialty pharmacy and infusion combination for high-cost biologic therapies.
- UnitedHealth Group / Optum Infusion: Vertically integrated payer-provider whose Optum platform includes infusion services; represents both a payer counterparty and a potential vertically integrated competitor for chronic-condition infusion patients.
- HCA Healthcare: Largest U.S. for-profit hospital system and the dominant hospital-based infusion channel (~55% market share); competes for the same infusion volume that Vivo is diverting to AIC settings.
- Walgreens Boots Alliance (VillageMD/Summit Health): Pharmacy-led primary and specialty care platform that increasingly incorporates infusion and complex therapies; could emerge as a channel competitor or strategic acquirer of AIC capacity.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Vivo Infusion social profiles
Digital presenceVivo Infusion compliance and trust
Trust signalCompliance1 record
Vivo Infusion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivo Infusion leadership team
Management profileNumber of profiles
Profiles12 records
Vivo Infusion subsidiaries and ownership
Company hierarchySubsidiaries8 records
Vivo Infusion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivo Infusion M&A and investment
M&A and investmentM&A5 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivo Infusion
What does Vivo Infusion do?
Vivo Infusion operates a national network of outpatient ambulatory infusion centers providing personalized IV therapy for chronic and complex conditions. The company administers over 100 advanced infusion therapies including monoclonal antibodies, immune globulin therapies, enzyme replacement therapies, TNF alpha inhibitors, and chemotherapy, integrated with in-house specialty pharmacies and a clinical research program that supports investigational infusion products at JCAHO-certified facilities.
Is Vivo Infusion a public or private company?
Vivo Infusion is a private company. It is classified as private equity controlled and is currently operating.
When was Vivo Infusion founded?
Vivo Infusion was founded in 2022. It employs 501 to 1,000 people.
Where is Vivo Infusion based?
Vivo Infusion is headquartered in Lakewood, United States, in the North America region.
How does Vivo Infusion make money?
One revenue line is on record: infusion Therapy Services.
Who are Vivo Infusion's main competitors?
Direct peers on record are IVX Health, Soleo Health, Pentec Health and KabaFusion. Broad incumbents are Option Care Health, Coram (CVS Health), BioPlus Specialty Pharmacy (Elevance Health), UnitedHealth Group / Optum Infusion, HCA Healthcare and Walgreens Boots Alliance (VillageMD/Summit Health).
Does Vivo Infusion have an API?
No public API is recorded for Vivo Infusion.
What industry is Vivo Infusion in?
Vivo Infusion's product category is Ambulatory Infusion Services. Its primary akta.pro industry code is HLAFABAF, Infusion Therapy Centers (Outpatient), with a secondary code of HLAFALAG, Infusion & Home Infusion Pharmacy Services. Its NAICS code is 621498 and its SIC code is 8093.